Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

2026 Sessions

Bridging Specialties for Better Care: The Cardiovascular-Dermatology Interface

Chronic inflammatory skin diseases like psoriasis, hidradenitis suppurativa, atopic dermatitis, and alopecia areata are now recognized as significant risk factors for cardiovascular disease. Meanwhile, cardiovascular conditions—like infective endocarditis, heart failure, and thromboembolism—can present with key skin findings that aid in diagnosis. This session explores the bidirectional relationship between skin and heart health, highlighting how therapies in one domain can impact the other, and emphasizes the need for interdisciplinary awareness. Despite growing evidence, clear screening guidelines for cardiovascular risk in dermatologic patients remain limited, making education and early recognition essential for improving outcomes.

Co-Host

Keynote Speaker

Saturday, March 14 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Brittany Weber

MD, PhD
Director, Cardio-Dermatology and Cardio-Rheumatology Program
University of Texas Southwestern Medical Center

Dr. Weber is the Director of the Cardio-Dermatology and Cardio-Rheumatology Program, and an Assistant Professor of Medicine at UT Southwestern Medical Center. She is a graduate of the University of Pennsylvania School of Medicine with an MD-PhD in Immunology. She received internal medicine training, including serving as a chief medical resident, and cardiovascular training, including an advanced cardiovascular imaging research fellowship at the Brigham and Women’s Hospital. Her clinical interests include cardiovascular risk stratification and prevention with patients with systemic inflammatory disorders. Her research leverages advanced cardiovascular imaging (stress/PET and coronary CT), biomarkers, and immunology to investigate the relationships between systemic inflammation and CVD, with a focus on the coronary microcirculation and novel metrics of atherosclerotic plaque imaging. Her multi-disciplinary clinical and research program includes close collaborations between cardiology, rheumatology, and dermatology. As a testament to her success in this short time frame, she is the recipient of the 2025 American College of Cardiology (ACC) Douglas P. Zipes Distinguished Young Scientist Award.

Your Questions, Their Answers: March Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, March 14 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Andrew Blauvelt

MD, MBA
Owner
Blauvelt Consulting, LLC

Dr. Blauvelt is Owner of Blauvelt Consulting, LLC. He received his BS at Purdue University, his MD at Michigan State University, and a healthcare MBA at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH, OHSU, and the Portland VA Medical Center as well as being Owner and President of Oregon Medical Research Center for 10 years. Dr. Blauvelt has published over 450 papers and spoken across the country and world on immunology, psoriasis, and atopic dermatitis. Within psoriasis research, his laboratory published key papers on the role of IL-23/Th17 biology in this disease. In recent years, he has been the international lead/senior investigator on numerous important clinical trials in psoriasis, atopic dermatitis, and other diseases, including KNOCKOUT. Dr. Blauvelt is also an elected member of the International Psoriasis Council and the International Eczema Council; he became Chair of the Medical Board for the National Psoriasis Foundation in 2023, an organization he has worked closely with for over 25 years in a variety of capacities.

Faculty

Brittany Weber

MD, PhD
Director, Cardio-Dermatology and Cardio-Rheumatology Program
University of Texas Southwestern Medical Center

Dr. Weber is the Director of the Cardio-Dermatology and Cardio-Rheumatology Program, and an Assistant Professor of Medicine at UT Southwestern Medical Center. She is a graduate of the University of Pennsylvania School of Medicine with an MD-PhD in Immunology. She received internal medicine training, including serving as a chief medical resident, and cardiovascular training, including an advanced cardiovascular imaging research fellowship at the Brigham and Women’s Hospital. Her clinical interests include cardiovascular risk stratification and prevention with patients with systemic inflammatory disorders. Her research leverages advanced cardiovascular imaging (stress/PET and coronary CT), biomarkers, and immunology to investigate the relationships between systemic inflammation and CVD, with a focus on the coronary microcirculation and novel metrics of atherosclerotic plaque imaging. Her multi-disciplinary clinical and research program includes close collaborations between cardiology, rheumatology, and dermatology. As a testament to her success in this short time frame, she is the recipient of the 2025 American College of Cardiology (ACC) Douglas P. Zipes Distinguished Young Scientist Award.

Redefining Remission and Low Disease Activity in Dermatology

The evolving concept of remission in dermatology is reshaping clinical expectations and research strategies. Recently, the National Psoriasis Foundation introduced a distinction between on-drug remission and off-drug remission. The International Eczema Council is working on similar distinctions. Faculty will discuss these new concepts that continue to gain traction as standards in research and practice.

Co-Host

Keynote Speaker

Saturday, April 11 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Your Questions, Their Answers: April Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, April 11 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

New Targets in Next-Generation Treatments for Atopic Dermatitis and Itch

Despite advances in Th2- and JAK/STAT-targeted therapies, many patients with atopic dermatitis (AD) continue to experience residual symptoms, especially pruritus. New approaches are exploring IL-31 inhibition and refined JAK-STAT modulation to address persistent itch, particularly in “clear-skin, persistent-itch” phenotypes. Additional targets include TSLP, IL-1 family cytokines, OX40/OX40L, and Th17/Th22 pathways. Adjunctive device-based modalities—such as phototherapy, transcutaneous electrical nerve stimulation, and cold plasma therapy—are also under investigation. This session will provide an overview of these next-generation therapies.

Co-Host

Keynote Speaker

Saturday, May 09 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Shawn Kwatra

MD
Chair
University of Maryland

Dr. Kwatra is the Joseph W. Burnett Endowed Professor and Chairman of Dermatology at the University of Maryland School of Medicine in Baltimore, MD, USA. His areas of clinical expertise include chronic pruritus, prurigo nodularis, atopic dermatitis, and dermatology for ethnic skin. He is funded by the National Institutes of Health and multiple foundations. He runs a basic and translational research laboratory along with a clinical trials unit and is funded by the National Institutes of Health and has been an author or co-author on over 250 publications. He is currently the Secretary-Treasurer of the Skin of Color Society and a member of the National Eczema Society Scientific and Medical Advisory Council.

Masterclass: Advancing the Identification and Management of Cutaneous Lupus Erythematosus: Bridging Clinical Challenges and Emerging Therapeutic Strategies

Cutaneous lupus erythematosus (CLE) is an interferon-driven autoimmune skin disease with three main subtypes—acute (ACLE), subacute (SCLE), and chronic (CCLE), including discoid lupus erythematosus and related variants. Overlap with systemic lupus erythematosus (SLE) and other dermatologic conditions complicates diagnosis and management, underscoring the importance of early recognition to prevent irreversible damage. Conventional treatments are often nonspecific, slow to act, and limited by tolerability and monitoring concerns, whereas emerging targeted therapies show promise. Given its chronic, relapsing course, optimized outcomes require multidisciplinary care and continued clinician education to improve diagnosis, treatment, and patient quality of life.

After participating in this educational initiative, learners should be able to:
• Describe the pathogenesis, clinical variations, and diagnosis of acute, subacute, and chronic CLE to support comprehensive assessment and timely treatment
• Evaluate current clinical data associated with available and emerging treatment options for CLE
• Implement evidence-based and individualized CLE care that incorporates an interdisciplinary approach to management

Supported by an educational grant from Biogen.

Co-Presenter

Saturday, May 09 8:30–9:15 AM
Faculty

Scott Elman

MD
Assistant Professor
Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine

Scott Elman, MD, FAAD is an Assistant Professor of Dermatology in the Dr. Phillip Frost Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine who also serves as the Director of Inpatient Dermatology Services at the University of Miami Hospital. Dr. Elman received his Medical Degree from Harvard Medical School in 2016, where he stayed to complete his combined residency in internal medicine and dermatology. His clinical and research interests include complex medical dermatology, rheumatologic dermatology and inpatient dermatology. He is an active member of the Medical Dermatology Society, the Rheumatologic Dermatology Society and the Society of Dermatology Hospitalists. Outside of the hospital, Dr. Elman enjoys cooking, traveling and spending time with his wife and two children.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Your Questions, Their Answers: May Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, May 09 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Shawn Kwatra

MD
Chair
University of Maryland

Dr. Kwatra is the Joseph W. Burnett Endowed Professor and Chairman of Dermatology at the University of Maryland School of Medicine in Baltimore, MD, USA. His areas of clinical expertise include chronic pruritus, prurigo nodularis, atopic dermatitis, and dermatology for ethnic skin. He is funded by the National Institutes of Health and multiple foundations. He runs a basic and translational research laboratory along with a clinical trials unit and is funded by the National Institutes of Health and has been an author or co-author on over 250 publications. He is currently the Secretary-Treasurer of the Skin of Color Society and a member of the National Eczema Society Scientific and Medical Advisory Council.

Hidradenitis Suppurativa: New Therapeutic Targets. Some May Surprise You!

Be prepared for anything after this session, which will discuss recent advances in hidradenitis suppurativa treatments. Biologic therapies and small-molecule drugs have expanded treatment options by targeting key components of the disease's immunopathogenesis. Biologics, including TNF-α inhibitors and interleukin-targeting agents, have demonstrated efficacy in reducing inflammation, abscess formation, and disease progression, while improving quality of life. Meanwhile, small-molecule therapies offer advantages such as oral delivery, novel intracellular targets, and immune modulation. Ongoing research is optimizing the use of these agents, exploring their long-term outcomes, and investigating combination approaches.

Co-Host

Keynote Speaker

Saturday, June 06 7:00–7:45 AM
Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Your Questions, Their Answers: June Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, June 06 10:00–10:30 AM
Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Hyperpigmentation Prevention and Treatment

Join leading dermatology experts for an engaging discussion on the prevention and treatment of hyperpigmentation, one of the most common and challenging concerns in clinical practice. Faculty will share practical approaches to early intervention, individualized treatment selection, and patient counseling, while exploring the roles of topical, oral, and procedural therapies. The conversation will also highlight the evolving science of photoprotection, strategies for managing refractory cases, and emerging advances that may reshape care. Designed to provide real-world insights and actionable clinical pearls, this session will equip attendees with practical strategies to improve outcomes for patients with hyperpigmentation.

Co-Host

Keynote Speaker

Saturday, August 08 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Andrew Alexis

MD, MPH
Professor of Clinical Dermatology
Weill Cornell Medicine

Andrew F. Alexis, MD, MPH, is a Professor of Clinical Dermatology at Weill Cornell Medicine whose work involves patient care, clinical research, and education in a broad range of dermatologic conditions, including inflammatory, pigmentary, and hair disorders. He is the former Chair of the Department of Dermatology at Mount Sinai Morningside and Mount Sinai West. Having served as Director of the first-of-its-kind Skin of Color Center for over 15 years, his work has helped to advance our understanding of dermatologic disorders that are more prevalent or nuanced in populations with skin of color.

Dr. Alexis received his medical degree from Columbia University Vagelos College of Physicians & Surgeons and his Master of Public Health at Columbia University Mailman School of Public Health. He completed his dermatology residency at Weill Cornell Medicine, followed by a fellowship in dermatopharmacology at NYU Langone’s Ronald O. Perelman Department of Dermatology.

Dr. Alexis has published more than 100 articles in peer-reviewed journals, including the British Journal of Dermatology, Journal of the American Academy of Dermatology, and JAMA Dermatology among others. He has co-edited four textbooks and authored over 10 book chapters.

Dr. Alexis has held numerous leadership positions in professional organizations including Past President of the Skin of Color Society, the New York Dermatological Society, and the New York Academy of Medicine Dermatology Section. He currently serves as a member of the Board of Directors of the American Academy Dermatology and Scarring Alopecia Foundation.

Masterclass: Optimizing Biologic Therapy in Psoriatic Arthritis: Translating Clinical Evidence into Patient-Centered Care

Psoriatic arthritis is a complex, multisystem inflammatory disease that requires individualized treatment to address diverse clinical manifestations and comorbidities. This session reviews the immunologic pathways driving PsA and the mechanisms of action of current biologic therapies. Faculty will examine emerging clinical trial data and practical considerations for comparing treatment options. Attendees will gain evidence-based strategies for selecting biologic therapies using a treat-to-target approach to improve long-term patient outcomes.

This activity is supported through an independent educational grant from UCB.

Co-Presenter

Saturday, August 08 8:30–9:15 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Your Questions, Their Answers: August Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, August 08 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Andrew Alexis

MD, MPH
Professor of Clinical Dermatology
Weill Cornell Medicine

Andrew F. Alexis, MD, MPH, is a Professor of Clinical Dermatology at Weill Cornell Medicine whose work involves patient care, clinical research, and education in a broad range of dermatologic conditions, including inflammatory, pigmentary, and hair disorders. He is the former Chair of the Department of Dermatology at Mount Sinai Morningside and Mount Sinai West. Having served as Director of the first-of-its-kind Skin of Color Center for over 15 years, his work has helped to advance our understanding of dermatologic disorders that are more prevalent or nuanced in populations with skin of color.

Dr. Alexis received his medical degree from Columbia University Vagelos College of Physicians & Surgeons and his Master of Public Health at Columbia University Mailman School of Public Health. He completed his dermatology residency at Weill Cornell Medicine, followed by a fellowship in dermatopharmacology at NYU Langone’s Ronald O. Perelman Department of Dermatology.

Dr. Alexis has published more than 100 articles in peer-reviewed journals, including the British Journal of Dermatology, Journal of the American Academy of Dermatology, and JAMA Dermatology among others. He has co-edited four textbooks and authored over 10 book chapters.

Dr. Alexis has held numerous leadership positions in professional organizations including Past President of the Skin of Color Society, the New York Dermatological Society, and the New York Academy of Medicine Dermatology Section. He currently serves as a member of the Board of Directors of the American Academy Dermatology and Scarring Alopecia Foundation.

Care of Inflammatory Scalp Conditions in SOC Patients

Join experts in skin of color dermatology for a practical discussion on the diagnosis and management of inflammatory scalp conditions in diverse patient populations. Faculty will explore the unique clinical presentation of common scalp disorders, including seborrheic dermatitis, scalp psoriasis, central centrifugal cicatricial alopecia, and traction alopecia, while addressing the influence of hair texture and cultural hair care practices on diagnosis and treatment. The discussion will highlight evidence-based management strategies, culturally responsive patient counseling, and practical approaches to improving treatment adherence and long-term outcomes for patients with inflammatory scalp disease.

Co-Host

Keynote Speaker

Saturday, September 19 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Oyetewa Boluwatito Asempa

MD, FAAD
Assistant Professor, Director of Skin of Color Clinic
Baylor College of Medicine, Department of Dermatology

Dr. Oyetewa Asempa is an Assistant Professor of Dermatology at Baylor College of Medicine, and the Director of the Skin of Color Clinic for Baylor's Department of Dermatology. She was born and raised in Atlanta, GA, and then went on to graduate summa cum laude from Howard University in Washington, DC. She completed her medical training at University of Illinois at Chicago College of Medicine, during which time she also completed a year of research at the National Institutes of Health. She completed her internship at George Washington University, and then her residency training at the Harvard Dermatology program, where she served as Chief Resident in her final year. She specializes in hair loss and scalp disorders. Outside of medicine, she enjoys writing short stories, as well as writing and performing spoken word poetry.

Your Questions, Their Answers: September Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, September 19 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Oyetewa Boluwatito Asempa

MD, FAAD
Assistant Professor, Director of Skin of Color Clinic
Baylor College of Medicine, Department of Dermatology

Dr. Oyetewa Asempa is an Assistant Professor of Dermatology at Baylor College of Medicine, and the Director of the Skin of Color Clinic for Baylor's Department of Dermatology. She was born and raised in Atlanta, GA, and then went on to graduate summa cum laude from Howard University in Washington, DC. She completed her medical training at University of Illinois at Chicago College of Medicine, during which time she also completed a year of research at the National Institutes of Health. She completed her internship at George Washington University, and then her residency training at the Harvard Dermatology program, where she served as Chief Resident in her final year. She specializes in hair loss and scalp disorders. Outside of medicine, she enjoys writing short stories, as well as writing and performing spoken word poetry.

Faculty

Peter Lio

MD, FAAD
Partner
Medical Dermatology Associates of Chicago

Peter Lio, MD, FAAD is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine and an adjunct Clinical Professor of Dermatology at the Icahn School of Medicine at Mount Sinai. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He serves as a board member and scientific advisory committee member emeritus for the National Eczema Association. He is a member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group, a Councilor for the International Eczema Council, and is a founding faculty member of the Integrative Dermatology Certificate Program. He has over 400 publications and 4 textbooks.

Innovation in Dermatology: From Clinical Trials to Precision Diagnosis

Co-Host

Panelist

Saturday, October 17 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Alexa Hetzel

PA-C, DMSc
Director of Clinical Trials and Physician Assistant
Schweiger Dermatology

Alexa Hetzel, DMSc, PA-C, is a board-certified Physician Assistant specializing in medical dermatology with over 12 years of experience in Dermatologoy and clinical research. She currently serves as a Principal Investigator and has participated as a sub-investigator in hundreds of dermatology clinical trials, contributing to the advancement of therapies across numerous inflammatory skin diseases.

Alexa is recognized as a national educator and key opinion leader in psoriasis and atopic dermatitis, delivering educational programs and speaking at regional and national conferences. She serves as a liason on various conference boards and is passionate about advancing the role of physician assistants and nurse practitioners through education, leadership, and research.

She earned her Doctor of Medical Science degree with a focus on quality improvement, completing a project that significantly reduced the time to biologic therapy initiation for patients with psoriasis through the implementation of a patient-centered education program. Her professional interests include clinical research, evidence-based practice, provider education, and improving access to innovative dermatologic therapies.

Faculty

Jennifer Stein

MD, PhD
Stewart J Rahr Professor of Dermatology, Associate Vice Chair Dermatology Faculty Practice
Ronald O Perelman Department of Dermatology, NYU Langone Health

Jennifer Stein, MD PhD is a professor at NYU School of Medicine where she serves as the Associate Vice Chair of the dermatology faculty practice and the associate director of the Pigmented Lesion Section. As a specialist in early detection of melanoma and management of patients with atypical moles, she uses advanced imaging methods such as dermoscopy and sequential dermoscopic imaging for melanoma surveillance. She has lectured and published widely about melanoma in special situations such as pregnancy, and in special locations such as on the face, hands and feet.

Your Questions, Their Answers: October Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Panelist

Saturday, October 17 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Faculty

Alexa Hetzel

PA-C, DMSc
Director of Clinical Trials and Physician Assistant
Schweiger Dermatology

Alexa Hetzel, DMSc, PA-C, is a board-certified Physician Assistant specializing in medical dermatology with over 12 years of experience in Dermatologoy and clinical research. She currently serves as a Principal Investigator and has participated as a sub-investigator in hundreds of dermatology clinical trials, contributing to the advancement of therapies across numerous inflammatory skin diseases.

Alexa is recognized as a national educator and key opinion leader in psoriasis and atopic dermatitis, delivering educational programs and speaking at regional and national conferences. She serves as a liason on various conference boards and is passionate about advancing the role of physician assistants and nurse practitioners through education, leadership, and research.

She earned her Doctor of Medical Science degree with a focus on quality improvement, completing a project that significantly reduced the time to biologic therapy initiation for patients with psoriasis through the implementation of a patient-centered education program. Her professional interests include clinical research, evidence-based practice, provider education, and improving access to innovative dermatologic therapies.

Faculty

Jennifer Stein

MD, PhD
Stewart J Rahr Professor of Dermatology, Associate Vice Chair Dermatology Faculty Practice
Ronald O Perelman Department of Dermatology, NYU Langone Health

Jennifer Stein, MD PhD is a professor at NYU School of Medicine where she serves as the Associate Vice Chair of the dermatology faculty practice and the associate director of the Pigmented Lesion Section. As a specialist in early detection of melanoma and management of patients with atypical moles, she uses advanced imaging methods such as dermoscopy and sequential dermoscopic imaging for melanoma surveillance. She has lectured and published widely about melanoma in special situations such as pregnancy, and in special locations such as on the face, hands and feet.

What Was Hot and Transformative at EADV meeting?

Join leading faculty for a lively discussion of the most impactful research and clinical updates presented at the European Academy of Dermatology and Venereology (EADV) Annual Meeting. Experts will highlight late-breaking data, emerging therapies, and evolving treatment strategies across key areas of dermatology, while offering perspective on how new evidence may influence clinical practice. Designed to distill the meeting's most relevant takeaways, this session will provide attendees with timely insights and practical pearls they can immediately apply to patient care.

Co-Host

Saturday, November 14 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Your Questions, Their Answers: November Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Saturday, November 14 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Masterclasses in Dermatology

Join an open, podcast-style conversation with leading dermatology faculty as they discuss the latest research shaping the field and spotlight high-interest, underserved areas of clinical practice. In this informal, engaging format, faculty will share expert perspectives, real-world experiences, and honest insights into emerging data, controversies, and gaps in care. Designed to spark thoughtful dialogue, this session offers attendees a fresh, accessible look at cutting-edge science and underrepresented topics, with practical takeaways to inform patient care and future research.

Co-Host

Saturday, December 19 7:00–7:45 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Your Questions, Their Answers: November Q&A

Join a panel of leading dermatology experts for a dynamic, interactive Q&A session addressing the most pressing questions facing today’s dermatology practices. This session will focus on real-world clinical challenges, emerging trends, and practical strategies to optimize patient care, practice efficiency, and clinical decision-making. Attendees will have the opportunity to engage directly with faculty, gain expert insights on controversial and evolving topics, and leave with actionable takeaways they can immediately apply in practice on Monday.

Moderator

Saturday, December 19 10:00–10:30 AM
Co-Chairs

Alice Gottlieb

MD, PhD
Department of Dermatology
UT Southwestern Medical Center

Dr. Alice B. Gottlieb is an internationally recognized expert in the field of psoriasis and psoriatic arthritis. Her research uses targeted immunobiologics as pathogenic probes, providing a new understanding of the pathogenesis of psoriasis and providing the foundation for biologic drug development in these two debilitating diseases. In addition, she is a noteworthy researcher, but she is also an exceptionally outstanding clinician and educator. She is triple board-certified in dermatology, rheumatology, and internal medicine, making her one of only a handful of doctors in the United States to be certified in all three specialties. Her research has helped the numerous students, residents, and fellows she has trained, as well as the dermatologic community at large, which wants to understand how to diagnose and manage psoriatic arthritis. Dr. Gottlieb is the recipient of numerous awards, including the American Academy of Dermatology’s (AAD) 2023 Master Dermatologist Award and the 2016 National Psoriasis Foundation (NPF) Outstanding Educator in Psoriatic Disease Award.

Co-Chairs

Joseph Merola

MD, MMSc, FAAD, FACR
Department of Dermatology and Department of Medicine, Division of Rheumatology
UT Southwestern Medical Center and O'Donnell School of Public Health

Joseph F. Merola, MD, MMSc is Chair of Dermatology at UT Southwestern Medical Center in Dallas, TX; he is Professor of Dermatology, Medicine and Rheumatology at UTSW and the Peter O’Donnell Jr School of Public Health. He holds the Mary Kay Distinguished Chair in Dermatology. Dr. Merola is board-certified in Dermatology, Internal Medicine, and Rheumatology. He earned his medical degree at the NYU School of Medicine and his Masters at Harvard Medical School. He completed an internship in Internal Medicine at the Hospital of the University of Pennsylvania, residency in Dermatology at NYU Medical Center. He continued with a residency in Internal Medicine and a fellowship in Rheumatology at the Brigham and Women’s Hospital / Harvard Medical School in Boston. He was elected to the Board of Directors of the American Academy of Dermatology, is the Founding President of PPACMAN, is on the Scientific and Medical Boards of the National Psoriasis Foundation, Board of the International Dermatology Outcome Measures Group and president-elect of GRAPPA, the Board of the American Skin Association, on the Medical and Scientific Board of the Lupus Foundation of America. He is also the recent past president of the Medical Dermatology Society and is president-elect of the Rheumatology-Dermatology Society. He is a councilor for the International Eczema Council as well as the International Psoriasis Council. He has served on multiple committees including the AAD Guidelines Committee. Dr. Merola has published over 340 peer-reviewed publications and received numerous awards for education, research and mentorship.

Back to top